ТОП просматриваемых книг сайта:
Stuart Walker
Список книг автора Stuart Walker
Аннотация
"More Portmanteau Plays" by Stuart Walker. Published by Good Press. Good Press publishes a wide range of titles that encompasses every genre. From well-known classics & literary fiction and non-fiction to forgotten−or yet undiscovered gems−of world literature, we issue the books that need to be read. Each Good Press edition has been meticulously edited and formatted to boost readability for all e-readers and devices. Our goal is to produce eBooks that are user-friendly and accessible to everyone in a high-quality digital format.
Аннотация
This book focuses largely on enabling technologies for network convergence. A principal aim is to show where parallel functions exist in fixed and mobile voice network architectures and to explain how these functions will be combined. The authors describe the components of a future converged architecture and consider the following key aspects: QoS Requirements, Proposed Solution Architectures, Protocol and Interface options, Underlying Network Issues and Security issues. The book also compares and describes initiatives from several standards bodies working to simplify to a clean architecture and a common set of protocols. The impact on a Multi Protocol Label Switching (MPLS) network, the preferred method of transport for the core network, will be considered in detail.
Аннотация
Benefit-risk assessment is at the centre of the approval process for every new medicine. The ability to assess the risks of a new medicine accurately and to balance these against the benefits the medicine could bring is critical for every regulatory authority and pharmaceutical company. Despite this there are very few tried and tested evaluative models currently available. The authors of this book have developed a new, pioneering tool for the assessment of benefits and risks for new medicines in development. This model utilises a multi-criteria decision analysis which involves selecting, scoring and weighting key benefit and risk attributes and leads to an overall appraisal of benefits and risks of medicines. Benefit-Risk Appraisal of Medicines establishes the background and criteria required to assess benefit and risk in general and reviews the current practices by regulatory authorities and the pharmaceutical industry, including those models currently available. It outlines the development and evaluation of the authors’ new model and analyses the implications of its implementation. Describes an innovative, systematic model which leads to transparent and responsible benefit-risk decision making Contributes important ideas to the debate on benefit-risk appraisal Provides a future framework for benefit-risk appraisal of medicines Benefit-Risk Appraisal of Medicines covers the entire process from the discovery of new medicines to their marketing and is ideal for all those who work in the pharmaceutical industry and regulatory authorities,, as well as post-graduate students of pharmaceutical medicine and clinical pharmacology.
